GPRC5D
protein-codingG protein-coupled receptor class C group 5 member D, the group of G protein-coupled receptors, Class C orphans
Gene summary
The protein encoded by this gene is a member of the G protein-coupled receptor family; however, the specific function of this gene has not yet been determined. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~11.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to GPRC5D variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_018654.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | ||||
| missense | 46 | 3 | 49 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 47 | 3 | 0 | 50 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_061124.1 | 3 | MANE Select | |
| Ensembl | ENSP00000228887.1 | 3 | MANE Select | |
| Ensembl | ENSP00000379624.3 | 2 | Standard | |
| Ensembl | ENSP00000801953.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- GPCRs, Class C Metabotropic glutamate, pheromone
Biological Process
- G protein-coupled receptor signaling pathway
- activation of protein kinase activity
Molecular Function
- G protein-coupled receptor activity
- protein kinase activator activity
Cellular Component
- plasma membrane
- integral component of membrane
- receptor complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000228887
- Coding exons
- 3
- Length
- 11373
- Individuals with no LoFs
- 124748
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 997
- Defined
- 125746
- p
- 0.00398
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.623 | 168 | 192 | 0.874 | 0.0000106 | 2243 |
| Missense (PolyPhen) | 47 | 63.756 | 0.73719 | 805 | ||
| Synonymous | -0.928 | 93 | 82.3 | 1.13 | 0.00000507 | 712 |
| Loss of Function | 1.85 | 7 | 14.6 | 0.478 | 8.88e-7 | 135 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0073 | 0.0073 | notable |
| Latino/Admixed American | 0.0014 | 0.0014 | notable |
| Ashkenazi Jewish | 0.0016 | 0.0016 | notable |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.0020 | 0.0020 | notable |
| European (Non-Finnish) | 0.0061 | 0.0060 | notable |
| South Asian | 0.0022 | 0.0022 | notable |
| Other | 0.0031 | 0.0031 | notable |
dbNSFP Gene Annotations
Source:
Recessive Scores
- pRec
- 0.106
Intolerance Scores
- LoFtool
- 0.320
- RVIS EVS
- 0.09
- RVIS percentile EVS
- 60.47
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.0930
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |